The latest pharma news from Brazil, including the partnership between Biophytis and Innovation Solutions Pharma; Merck's 100 years in Brazil;…

Mexican voters will be heading to the polls next June for what will be the largest election process in the country’s history with concurrent state…

Indian pharma companies have been building a broader presence in LatAm markets over the past two decades. With well-established trade relations…

A roundup of some of the latest news from Latin American pharma, including Acino's acquisition of M8 Pharmaceuticals; AstraZeneca's growth in Mexico;…

Writing in the August edition of DIA’s Global Forum magazine, Silvia B. Bendiner of WESSX Inc. and Belkis Romeu call for greater regulatory…

There have been both ups and downs in AbbVie’s recent history. After proving its staying power with the celebration of its 10-year anniversary as an…

The latest from Mexican pharma, including the distribution agreement between Dow and Azelis, Neuraxpharm's new LatAm subsidiaries in Mexico and…

GSK has undergone a number of changes in recent years. After driving a major transformation that began in 2017 to strengthen its R&D performance,…

Writing in the July 2023 edition of DIA’s Global Forum magazine, Mariana Abdala of Crystal Research outlines the vast room for improvement in Latin…

Japanese-headquartered Takeda has been undergoing a transformation in recent years, becoming the global leader in rare diseases with the acquisition…

The latest pharma news from Brazil, including Daiichi Sankyo's new plant; Bristol Myers Squibb's re-entry into Brazil's cardiology market; the Anvisa…

A vibrant and diverse continent, home to over 650 million people and the highest life expectancy among developing regions, Latin America is now…